Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Core Scientific, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Core Scientific, Inc.’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 7:08 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001839341-26-000014
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Other operating assets and liabilities, net | (32,451) | (8,004) |
| Net cash provided by (used in) operating activities | 230,949 | (11,041) |
| Cash flows from Investing Activities: | ||
| Purchases of property, plant and equipment | (954,244) | (205,259) |
| Proceeds from sales of property and equipment | 3,927 | 1,671 |
| Acquisitions of land and development rights | (232,500) | — |
| Other investing activities | (74) | (5,036) |
| Net cash used in investing activities | (1,182,891) | (208,624) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Core Scientific, Inc.'s capex?
- Core Scientific, Inc. (CORZ) reported capex of $565.02M in Q2 2026.
- How has Core Scientific, Inc.'s capex changed year-over-year?
- Core Scientific, Inc.'s capex increased by 365.9% year-over-year, from $121.28M to $565.02M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Core Scientific, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude